Volume 31, Issue 2 (July 2024)                   J Birjand Univ Med Sci. 2024, 31(2): 190-194 | Back to browse issues page

Research code: 34421
Ethics code: IR.TUMS.MEDICINE.REC.1397.041


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azadvari M, Emami Razavi S Z, Hosseini M, Guitynavard F. Posterior Tibial Nerve Stimulation in overactive bladder: application and how to do it: Letter to Editor. J Birjand Univ Med Sci. 2024; 31 (2) :190-194
URL: http://journal.bums.ac.ir/article-1-3355-en.html
1- Department of physical medicine and rehabilitation department, Sina hospital, Tehran university of medical sciences, Tehran, Iran
2- Department of Physical Medicine and Rehabilitation, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran , zemamirazavi@gmail.com
3- Department of Physical Medicine and Rehabilitation, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
4- Department of Urology, Sina hospital, Tehran university of medical sciences, Tehran, Iran
Abstract:   (405 Views)
Lower urinary tract problems, including overactive bladder, are one of the most common diseases that increase with age and impose an enormous economic, psychological, and social burden on society. There are pharmacological and non-pharmacological treatments for this problem. Stimulation of the posterior tibial nerve from the medial malleolus area, which is called percutaneous tibial nerve stimulation (PTNS), is one of the recommended treatment methods for overactive bladder, which has been recently noticed and applied in the treatment of this disease. In this method, the posterior tibial nerve is stimulated from the lower leg (medial malleolus area) using a needle electrode or a surface electrode during consecutive sessions. This method works based on neuromodulation theory, which is minimally invasive and safe but time-consuming. In the available studies, this method has been able to significantly help patients with overactive bladder without underlying causes or even with underlying causes, such as neurological disorders. Considering the beneficial therapeutic effects of this method, in this study, we decided to review the use of PTNS in urinary problems, including overactive bladder, as well as thoroughly explain its performance and side effects.
Full-Text [PDF 210 kb]   (172 Downloads)    
Type of Study: Letter to Editor | Subject: Rehabilitation
Received: 2023/12/30 | Accepted: 2024/05/17 | ePublished ahead of print: 2024/06/30 | ePublished: 2024/08/5

References
1. Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol. 2006; 175(3 Pt 2): S5-10. DOI: 10.1016/S0022-5347(05)00313-7 [DOI:10.1016/S0022-5347(05)00313-7]
2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010; 21(1): 5-26. DOI: 10.1007/s00192-009-0976-9 [DOI:10.1007/s00192-009-0976-9]
3. Abello A, Das AK. Electrical neuromodulation in the management of lower urinary tract dysfunction: evidence, experience and future prospects. Ther Adv Urol. 2018; 10(5): 165-73. DOI: 10.1177/1756287218756082 [DOI:10.1177/1756287218756082]
4. Sayner AM, Rogers F, Tran J, Jovanovic E, Henningham L, Nahon I. Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review. Neuromodulation. 2022; 25(8): 1086-96. DOI: 10.1016/j.neurom.2022.04.034 [DOI:10.1016/j.neurom.2022.04.034]
5. Al-Danakh A, Safi M, Alradhi M, Almoiliqy M, Chen Q, Al-Nusaif M, et al. Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines. Parkinsons Dis. 2022; 2022: 2700227. DOI: 10.1155/2022/2700227 [DOI:10.1155/2022/2700227]
6. Caldwell KP. The electrical control of sphincter incompetence. Lancet. 1963; 2(7300): 174-5. DOI: 10.1016/s0140-6736(63)92807-1 [DOI:10.1016/S0140-6736(63)92807-1]
7. Bapir R, Bhatti KH, Eliwa A, Garcia-Perdomo HA, Gherabi N, Hennessey D, et al. Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials. Arch Ital Urol Androl. 2022; 94(4): 492-506. DOI: 10.4081/aiua.2022.4.492 [DOI:10.4081/aiua.2022.4.492]
8. Govier FE, Litwiller S, Nitti V, Kreder KJ, Jr., Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001; 165(4): 1193-8. PMID: 11257669 [DOI:10.1016/S0022-5347(05)66469-5]
9. Finazzi-Agro E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol. 2010; 184(5): 2001-6. DOI: 10.1016/j.juro.2010.06.113 [DOI:10.1016/j.juro.2010.06.113]
10. Dmochowski RR, Peters KM, Morrow JD, Guan Z, Gong J, Sun F, et al. Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder. Urology. 2010; 75(1): 62-8. DOI: 10.1016/j.urology.2009.09.018 [DOI:10.1016/j.urology.2009.09.018]
11. Martin-Garcia M, Crampton J. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Physiotherapy. 2019; 105(4): 469-75. DOI: 10.1016/j.physio.2018.12.002 [DOI:10.1016/j.physio.2018.12.002]
12. Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010; 183(4): 1438-43. DOI: 10.1016/j.juro.2009.12.036 [DOI:10.1016/j.juro.2009.12.036]
13. Yoong W, Shah P, Dadswell R, Green L. Sustained effectiveness of percutaneous tibial nerve stimulation for overactive bladder syndrome: 2-year follow-up of positive responders. Int Urogynecol J. 2013; 24(5): 795-9. DOI: 10.1007/s00192-012-1936-3 [DOI:10.1007/s00192-012-1936-3]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb